Skip to main content
. 2020 Jul 31;11:520. doi: 10.3389/fendo.2020.00520

Table 3.

Univariate and multivariate analyses for clinical factors associated with levothyroxine supplementation.

No levothyroxine (n = 87) Levothyroxine (n = 169) Univariate Multivariate
OR (95% CI) p-value OR (95% CI) p-value
Age (years, mean ± SD) 43.31 ± 10.21 44.04 ± 11.28 1.006 (0.982–1.030) 0.614 1.002 (0.976–1.028) 0.889
Sex (Female) 70 (80.5%) 134 (79.3%) 1.076 (0.563–2.055) 0.826 1.138 (0.570–2.271) 0.714
Preoperative TSH (mcIU/mL, mean ± SD) 1.40 ± 0.59 1.99 ± 1.02 2.229 (1581–3.142) <0.001 2.271 (1.598–3.227) <0.001
Thyroiditis 22 (25.3%) 65 (38.5%) 1.847 (1.040–3.279) 0.036 2.021 (1.092–3.738) 0.025

TSH, thyroid stimulating hormone; SD, standard deviation; OR, odds ratio; CI, confidence interval.